Healthcare -
Biotechnology - NASDAQ - US
$ 6.96
0 %
$ 476 M
Market Cap
-1.21
P/E
Price Target
Average
206.51%
Revenue Forecast
Estimate
935.40%
EBIT
Estimate
67.68%
Net Income
Estimate
33.97%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Phathom Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for PHAT of $21.3 , with forecasts ranging from
a
low of
$12 to a high of $28 .
PHAT Lowest Price Target
Wall Street Target
12 USD
72.41%
PHAT Average Price Target
Wall Street Target
21.3 USD
206.51%
PHAT Highest Price Target
Wall Street Target
28 USD
302.30%
REVENUE FORECAST
Revenue Forecast Chart PHAT
EBIT FORECAST
EBIT Forecast Chart PHAT
NET INCOME FORECAST
Net Income Chart PHAT